The current ‘gold standard’ of p16INK4a staining that is used for the detection of HPV in patients with non-OPC and OPMD has been shown to have several drawbacks [57,58,59]. This evidence concerns the gene CDKN2A and oculopharyngeal muscular dystrophy.